Bristol-Myers Squibb Company (NYSE: BMY) said it will conduct a comprehensive review of its business and research and development operations ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE